Literature DB >> 21255854

New developments in dry powder pulmonary vaccine delivery.

Tomás Sou1, Els N Meeusen, Michael de Veer, David A V Morton, Lisa M Kaminskas, Michelle P McIntosh.   

Abstract

Pulmonary immunization has gained increased recognition as a means of triggering both a mucosal and systemic immune response without the use of needles. The appropriate formulation of antigens in a dry, solid state can result in improved stability, thereby removing cold-chain storage complications associated with conventional liquid-based vaccines. The particulate nature of dry powder vaccines could also induce a better immune response. This review describes our current understanding of pulmonary immunization, including possible barriers facing the development of pulmonary vaccines, and discusses recent advances in spray-drying technologies applicable to the production of dry powder formulations for pulmonary vaccine delivery.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21255854     DOI: 10.1016/j.tibtech.2010.12.009

Source DB:  PubMed          Journal:  Trends Biotechnol        ISSN: 0167-7799            Impact factor:   19.536


  24 in total

Review 1.  Devices for dry powder drug delivery to the lung.

Authors:  Kai Berkenfeld; Alf Lamprecht; Jason T McConville
Journal:  AAPS PharmSciTech       Date:  2015-05-12       Impact factor: 3.246

2.  Development and Characterization of a Dry Powder Formulation for Anti-Tuberculosis Drug Spectinamide 1599.

Authors:  Ian E Stewart; Pradeep B Lukka; Jiuyu Liu; Bernd Meibohm; Mercedes Gonzalez-Juarrero; Miriam S Braunstein; Richard E Lee; Anthony J Hickey
Journal:  Pharm Res       Date:  2019-07-18       Impact factor: 4.200

Review 3.  Veterinary vaccine nanotechnology: pulmonary and nasal delivery in livestock animals.

Authors:  Daniella Calderon-Nieva; Kalhari Bandara Goonewardene; Susantha Gomis; Marianna Foldvari
Journal:  Drug Deliv Transl Res       Date:  2017-08       Impact factor: 4.617

Review 4.  Nanocarriers targeting dendritic cells for pulmonary vaccine delivery.

Authors:  Nitesh K Kunda; Satyanarayana Somavarapu; Stephen B Gordon; Gillian A Hutcheon; Imran Y Saleem
Journal:  Pharm Res       Date:  2012-10-09       Impact factor: 4.200

Review 5.  Nebulised antibiotherapy: conventional versus nanotechnology-based approaches, is targeting at a nano scale a difficult subject?

Authors:  Esther de Pablo; Raquel Fernández-García; María Paloma Ballesteros; Juan José Torrado; Dolores R Serrano
Journal:  Ann Transl Med       Date:  2017-11

6.  Engineering of an inhalable DDA/TDB liposomal adjuvant: a quality-by-design approach towards optimization of the spray drying process.

Authors:  Pall Thor Ingvarsson; Mingshi Yang; Helle Mulvad; Hanne Mørck Nielsen; Jukka Rantanen; Camilla Foged
Journal:  Pharm Res       Date:  2013-06-22       Impact factor: 4.200

7.  Bovine serum albumin adsorbed PGA-co-PDL nanocarriers for vaccine delivery via dry powder inhalation.

Authors:  Nitesh K Kunda; Iman M Alfagih; Sarah Rachel Dennison; Hesham M Tawfeek; Satyanarayana Somavarapu; Gillian A Hutcheon; Imran Y Saleem
Journal:  Pharm Res       Date:  2014-10-09       Impact factor: 4.200

8.  Micro-fractional epidermal powder delivery for improved skin vaccination.

Authors:  Xinyuan Chen; Garuna Kositratna; Chang Zhou; Dieter Manstein; Mei X Wu
Journal:  J Control Release       Date:  2014-08-15       Impact factor: 9.776

Review 9.  Physical stability of dry powder inhaler formulations.

Authors:  Nivedita Shetty; David Cipolla; Heejun Park; Qi Tony Zhou
Journal:  Expert Opin Drug Deliv       Date:  2019-12-13       Impact factor: 6.648

10.  A stable live bacterial vaccine.

Authors:  Nitesh K Kunda; Denis Wafula; Meilinn Tram; Terry H Wu; Pavan Muttil
Journal:  Eur J Pharm Biopharm       Date:  2016-03-25       Impact factor: 5.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.